IQ-AI Limited (IQAI.L) Research

Headquartered in Saint Helier, Jersey, IQ-AI Limited is a technology firm that develops sophisticated software solutions for the healthcare sector, with operations extending to the United States. Its diverse product suite supports medical imaging and diagnostics. Key offerings include IB Clinic, a set of post-processing plug-ins designed to enhance existing image visualization platforms; IB Rad Tech, an engine for streamlining custom clinical workflows; and IB Neuro, which processes MR data to create detailed parametric perfusion maps. The company also provides IB Delta Suite for essential radiology functions such as image co-registration and subtraction. Specialized tools further include IB DCE for analyzing T1-weighted images to derive perfusion and permeability parameters, and IB Diffusion for generating various parameter maps from MR diffusion-weighted data, such as apparent diffusion coefficients and IVIM. Additionally, IB StoneChecker assists clinical decision-making related to kidney stones. Beyond these software innovations, IQ-AI Limited offers valuable consulting services. The company adopted its current name in October 2018, having previously operated as Flying Brands Limited.

Open IQ-AI Limited (IQAI.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.